Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1927 1
1929 1
1942 1
1947 4
1953 1
1956 2
1963 2
1965 2
1966 4
1967 4
1968 2
1970 3
1971 1
1972 6
1973 2
1974 1
1975 3
1976 4
1977 8
1978 5
1979 1
1980 6
1981 1
1982 2
1983 3
1984 9
1985 6
1986 15
1987 10
1988 8
1989 11
1990 17
1991 15
1992 11
1993 12
1994 9
1995 11
1996 10
1997 14
1998 12
1999 17
2000 14
2001 10
2002 18
2003 28
2004 31
2005 24
2006 27
2007 39
2008 38
2009 36
2010 41
2011 56
2012 38
2013 39
2014 49
2015 52
2016 63
2017 54
2018 74
2019 62
2020 62
2021 47
Text availability
Article attribute
Article type
Publication date

Search Results

1,060 results
Results by year
Filters applied: . Clear all
Page 1
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months.
Wajnberg A, Amanat F, Firpo A, Altman DR, Bailey MJ, Mansour M, McMahon M, Meade P, Mendu DR, Muellers K, Stadlbauer D, Stone K, Strohmeier S, Simon V, Aberg J, Reich DL, Krammer F, Cordon-Cardo C. Wajnberg A, et al. Among authors: stone k. Science. 2020 Dec 4;370(6521):1227-1230. doi: 10.1126/science.abd7728. Epub 2020 Oct 28. Science. 2020. PMID: 33115920 Free PMC article.
Treatment of Idiopathic Castleman Disease.
van Rhee F, Greenway A, Stone K. van Rhee F, et al. Among authors: stone k. Hematol Oncol Clin North Am. 2018 Feb;32(1):89-106. doi: 10.1016/j.hoc.2017.09.008. Hematol Oncol Clin North Am. 2018. PMID: 29157622 Free article. Review.
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.
van Rhee F, Voorhees P, Dispenzieri A, FossƄ A, Srkalovic G, Ide M, Munshi N, Schey S, Streetly M, Pierson SK, Partridge HL, Mukherjee S, Shilling D, Stone K, Greenway A, Ruth J, Lechowicz MJ, Chandrakasan S, Jayanthan R, Jaffe ES, Leitch H, Pemmaraju N, Chadburn A, Lim MS, Elenitoba-Johnson KS, Krymskaya V, Goodman A, Hoffmann C, Zinzani PL, Ferrero S, Terriou L, Sato Y, Simpson D, Wong R, Rossi JF, Nasta S, Yoshizaki K, Kurzrock R, Uldrick TS, Casper C, Oksenhendler E, Fajgenbaum DC. van Rhee F, et al. Among authors: stone k. Blood. 2018 Nov 15;132(20):2115-2124. doi: 10.1182/blood-2018-07-862334. Epub 2018 Sep 4. Blood. 2018. PMID: 30181172 Free PMC article.
Effect on Patient Safety of a Resident Physician Schedule without 24-Hour Shifts.
Landrigan CP, Rahman SA, Sullivan JP, Vittinghoff E, Barger LK, Sanderson AL, Wright KP Jr, O'Brien CS, Qadri S, St Hilaire MA, Halbower AC, Segar JL, McGuire JK, Vitiello MV, de la Iglesia HO, Poynter SE, Yu PL, Zee PC, Lockley SW, Stone KL, Czeisler CA; ROSTERS Study Group. Landrigan CP, et al. Among authors: stone kl. N Engl J Med. 2020 Jun 25;382(26):2514-2523. doi: 10.1056/NEJMoa1900669. N Engl J Med. 2020. PMID: 32579812 Free PMC article. Clinical Trial.
Germline hypomorphic CARD11 mutations in severe atopic disease.
Ma CA, Stinson JR, Zhang Y, Abbott JK, Weinreich MA, Hauk PJ, Reynolds PR, Lyons JJ, Nelson CG, Ruffo E, Dorjbal B, Glauzy S, Yamakawa N, Arjunaraja S, Voss K, Stoddard J, Niemela J, Zhang Y, Rosenzweig SD, McElwee JJ, DiMaggio T, Matthews HF, Jones N, Stone KD, Palma A, Oleastro M, Prieto E, Bernasconi AR, Dubra G, Danielian S, Zaiat J, Marti MA, Kim B, Cooper MA, Romberg N, Meffre E, Gelfand EW, Snow AL, Milner JD. Ma CA, et al. Among authors: stone kd. Nat Genet. 2017 Aug;49(8):1192-1201. doi: 10.1038/ng.3898. Epub 2017 Jun 19. Nat Genet. 2017. PMID: 28628108 Free PMC article.
Clinical response to omalizumab in patients with hereditary Ī±-tryptasemia.
Mendoza Alvarez LB, Barker R, Nelson C, DiMaggio T, Stone KD, Milner JD, Rosenthal JA, Petroni DH, Glover SC, Lyons JJ. Mendoza Alvarez LB, et al. Among authors: stone kd. Ann Allergy Asthma Immunol. 2020 Jan;124(1):99-100.e1. doi: 10.1016/j.anai.2019.09.026. Epub 2019 Oct 9. Ann Allergy Asthma Immunol. 2020. PMID: 31605754 No abstract available.
Hypomorphic caspase activation and recruitment domain 11 (CARD11) mutations associated with diverse immunologic phenotypes with or without atopic disease.
Dorjbal B, Stinson JR, Ma CA, Weinreich MA, Miraghazadeh B, Hartberger JM, Frey-Jakobs S, Weidinger S, Moebus L, Franke A, SchƤffer AA, Bulashevska A, Fuchs S, Ehl S, Limaye S, Arkwright PD, Briggs TA, Langley C, Bethune C, Whyte AF, Alachkar H, Nejentsev S, DiMaggio T, Nelson CG, Stone KD, Nason M, Brittain EH, Oler AJ, Veltri DP, Leahy TR, Conlon N, Poli MC, Borzutzky A, Cohen JI, Davis J, Lambert MP, Romberg N, Sullivan KE, Paris K, Freeman AF, Lucas L, Chandrakasan S, Savic S, Hambleton S, Patel SY, Jordan MB, Theos A, Lebensburger J, Atkinson TP, Torgerson TR, Chinn IK, Milner JD, Grimbacher B, Cook MC, Snow AL. Dorjbal B, et al. Among authors: stone kd. J Allergy Clin Immunol. 2019 Apr;143(4):1482-1495. doi: 10.1016/j.jaci.2018.08.013. Epub 2018 Aug 28. J Allergy Clin Immunol. 2019. PMID: 30170123 Free PMC article.
1,060 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page